The IXP Lifesciences Catalyst Fund has a greenshoe option of Rs 100 crore with an investment horizon of 3-5 years targeting ...

The portfolio will comprise 20-25 B2B startups spanning Pre-seed to Series A stages, addressing innovation gaps in areas such as pharmaceuticals, biotechnology, medical technology, specialty chemicals ...

A joint report by the Institute for Deep Tech Innovation (DEEP) at ESMT Berlin and the Bertelsmann Stiftung highlights Germany’s immense innovation potential in the biotech sector. However, this ...

Although the U.S. is still the leading country behind biotech innovation, China is close behind, according to a Johnson & Johnson (NYSE:JNJ) business development executive. Nauman Shah, global head of ...

A pair of Chinese manufacturers whose active pharmaceutical ingredients (API) were previously shipped to the U.S. | The FDA ...

Alloy Therapeutics Inc. (“Alloy”), a biotechnology ecosystem company dedicated to democratizing access to cutting edge drug ...

Biotech Showcase™ 2025 Opens the Year with More than 3,000 Attendees, 340+ Presenting Companies, 1,020+ Investors and 85+ Members of the Media ...

Immunotherapy, medical devices, and pharmaceutical innovation are also transforming the biopharma industry. Emerging companies in synthetic biology and cell therapy are disrupting traditional ...

A Scottish biotech innovation centre added 100 new members to its network in less than a year, signalling the growth in ...

The fund aims to build a portfolio of 20-25 companies that address gaps in services and products across pharmaceuticals, ...

Biotech Showcase™ 2025 Opens the Year with ... These vital one-to-one engagements are the wellspring of deals that drive innovation in our industry. Plus, tired of market noise?